Download PDF
1 / Pages

Other users also viewed these articles

Recommendations of the Spanish Society of Nephrology for the management of mineral and bone metabolism disorders in patients with chronic kidney disease: 2021 (SEN-MM) José-Vicente Torregrosa; Jordi Bover; Mariano Rodríguez Portillo; Emilio González Parra; María Dolores Arenas; Francisco Caravaca; María-Luisa González Casaus; Alejandro Martín-Malo; Juan Francisco Navarro-González; Víctor Lorenzo; Pablo Molina; Minerva Rodríguez; Jorge Cannata Andia;
Nefrologia (English Version). 2023;43 Supl 1:1-36
Ultrafiltration rate adjusted to body weight and mortality in hemodialysis patients Raul Fernandez-Prado; Jessy Korina Peña-Esparragoza; Begoña Santos-Sánchez-Rey; Mónica Pereira; Alejandro Avello; Elena Gomá-Garcés; Marina González-Rivera; Guillermo González-Martin; Carolina Gracia-Iguacel; Ignacio Mahillo; Alberto Ortiz; Emilio González-Parra;
Nefrologia (English Version). 2021;41:426-35
Efficacy and safety of sucroferric oxyhydroxide in the treatment of hyperphosphataemia in chronic kidney disease in Asturias. FOSFASTUR study J. Emilio Sanchez-Alvarez; Elena Astudillo Cortés; Miguel Seras Mozas; Raúl García Castro; Carlos Miguel Hidalgo Ordoñez; Ana Cristina Andrade López; Catalina Ulloa Clavijo; Anna Gallardo Pérez; Carmen Rodríguez Suarez;
Nefrologia (English Version). 2021;41:45-52